Analyst
Jones Research
Equibles does not estimate personal net worth.
Sumit Roy is recorded as Analyst at Jones Research. Sumit Roy has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for Nuvation Bio Inc. on November 3, 2025. The companies whose calls Sumit Roy spoke on are classified in the Healthcare sector.
“On the projection of the – right now you are getting almost 15 patients every week, so 60 a month. Could you give us some guidance on is that a fair number for next couple quarters to go with or following the initial excitement we should trim the total number of new patients a little bit?”
“Curious, when you're talking to the community center physicians, are you seeing any direct effect by Iprosi being the preferred NCCN agent?”
“On the approval milestone payment from Sager, is there any additional color available on the – is there a breakdown of the $250 million as a lump sum? And second is the unit price.”
“During your market research with the physicians, anything, trying to understand how much physician education is needed in terms of features of tele-direction that needs to stand out, how, or how the adverse events will be managed, if you can provide any color on that.”
Jones Research
Analyst
Transcript header (unverified)
NUVB
Biotechnology · Healthcare
